1. Gouider R, LeGuern E, Gugenheim M, et al. Clinical, electrophysiologic, and mo- lecular correlations in 13 families with hereditary neuropathy with liability to pres- 15.
sure palsies and a chromosome 17p11.2 deletion. Neurology. 1995;45:2018-2023.
2. Amato AA, Gronseth GS, Callerame KJ, Kagan-Hallet KS, Bryan WW, Barohn RJ. 16.
Tomaculous neuropathy: a clinical and electrophysiological study in patients with
and without 1.5-Mb deletions in chromosome 17p11.2. Muscle Nerve. 1996;
19:16-22. 17.
3. Snipes GJ, Suter U, Welcher AA, Shooter EM. Characterization of a novel pe- ripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol. 1992;
117:225-238.
18.
4. Baechner D, Liehr T, Hameister H, et al. Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during
murine development. J Neurosci Res. 1995;42:733-741.
19.
5. Parmantier E, Cabon F, Braun C, D'Urso D, Muller HW, Zalc B. Peripheral myelin
protein-22 is expressed in rat and mouse brain and spinal cord motoneurons.
Eur J Neurosci. 1995;7:1080-1088.
20.
6. Amato AA, Barohn RJ. Hereditary neuropathy with liability to pressure palsies:
association with central nervous system demyelination. Muscle Nerve. 1996;
19:770-773.
7. Schneider C, Reiners K, Friedl W, Ebner R, Toyka KV. Involvement of the visual 21.
pathway in hereditary neuropathy with liability to pressure palsies. J Neurol. 2000;
247:222-223.
8. Dackovic J, Rakocevic-Stojanovic V, Pavlovic S, et al. Hereditary neuropathy with 22.
liability to pressure palsies associated with central nervous system myelin lesions.
Eur J Neurol. 2001;8:689-692.
